Mr. Joyce served as President and Chief Executive Officer of Danaher Corporation, a global life sciences and diagnostics innovator, from September 2014 to September 2020, and as a senior advisor to Danaher from September 2020 to February 2021. During his tenure he oversaw the $13.6 billion acquisition of Pall Corporation and more than two dozen other strategic transactions. He joined Danaher in 1989 and served in leadership positions across multiple functions and businesses, and also served as a director of Danaher from 2014 to 2020. At Roper he serves on the Audit and Compensation Committees.
Where the filing does not disclose a value, this page states "Not disclosed" rather than estimating. Smaller filers are exempt from disclosing metric targets and achievement, and larger filers may omit forward targets for competitive reasons.